$2.35 -0.01 (-0.42%)
11/27/2009 1:00 PM

Clarient, Inc. (CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Featured Broker Partners